Skip to main content

Table 3 Final cluster solution–demographic, genetic and CFS criteria adherence differences

From: Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers

Cluster

1: Pain tolerant & good cognitions (n = 40)

2: Restored HPA dynamics (n = 15)

3: Orthostatic intolerance (n = 20)

4: Low-grade inflammation (n = 4)

5: Pain intolerant & poor cognitions (n = 33)

6: High vagal activity (n = 3)

p-valuec

Sex-no. of males (%)

7 (17.5)

4 (26.7)

7 (35.0)

1 (25.0)

10 (30.3)

1 (33.3)

0.639

Age, years-mean [95% CI]

15.7 [15.3, 16.3]

15.7 [14.9, 16.5]

15.0 [14.2, 15.7]

16.5 [15.1, 18.0]

14.8 [14.3, 15.4]

15.4 [11.2, 19.6]

0.074

BMI, kg/m2-mean [95% CI]

22.3 [21.0, 23.1]

23.2[20.4, 26.1]

20.4 [17.9, 22.6]

22.8 [11.6, 33.9]

20.7 [19.4, 22.0]

18.3 [11.4, 25.1]

0.128

Disease duration, months-mean [95% CI]

19.4 [15.9, 22.9]

25.1 [10.8, 39.5]

22.0 [16.0, 27.9]

28.0 [n.a.]

19.3 [14.8, 23.9]

30.3 [n.a.]

0.538

Fukuda-no. fulfilling criteria (%)a

27 (71.1)

9 (60.0)

16 (80.0)

4 (100.0)

25 (78.1)

3 (100.0)

0.564

Canada-no. fulfilling criteria (%)b

13 (35.1)

3 (20.0)

6 (30.0)

1 (25.0)

22 (68.8)

1 (33.3)

0.006

COMT [SNP rs4680]-no. (%)

 AA

10 (25.0)

4 (26.7)

8 (40.0)

1 (25.0)

13 (39.4)

0 (0)

0.616

 AG/GG

30 (75.0)

11 (73.3)

12 (60.0)

3 (75.0)

20 (60.6)

3 (100.0)

SLC6A4 [5-HTTLPR allele & SNP rs25531]-no. (%)

 SS/SLG

11 (27.5)

3 (20.0)

2 (10.0)

3 (75.0)

9 (27.3)

1 (66.7)

0.139

 SA/LALG/LALA

29 (27.5)

20 (80.0)

18 (90.0)

1 (25.0)

24 (72.7)

2 (33.3)

  1. HPA: hypothalamus–pituitary–adrenal; BMI: Body mass index; SD: Standard deviation; ADRA2A: alpha-2A adrenergic receptor gene; COMT: Catechol-O-methyltransferase gene; ADRB2: beta-2 adrenergic receptor gene; SLC6A4: serotonin transporter (5-HTT) gene; C: Cytosine; G: Guanine; A: Adenosine; LPR: long tandem repeats; S: short allele; L: long allele
  2. aNumber of patients fulfilling the CDC Fukuda 1994 diagnostic criteria for Chronic Fatigue Syndrome [Fukuda 1994]
  3. bNumber of patients fulfilling the Canada 2003 diagnostic criteria for Chronic Fatigue Syndrome [Carruthers 2003]
  4. cUnadjusted p-values. The p-values are based on the Fischer exact test or one-way ANOVA, as appropriate. Only group 1–3 and 5 were used in the statistical analyses of continuous variables due to few participants in group 4 and 6